Editor's Picks

I'm very interested in sharing companies that we learn about throughout our daily research. Here we meet four from around the globe, three of which are still in the product development phase.

Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology's impact.

Companies across orthopedics with products in development or recently cleared continue to secure funding to fuel commercialization efforts.